The mark consists of stylized word "Baricitinib" with the first four letters "Bari" bolded and two curved lines, bands or streaks, one curving down and one curving up intersecting over the letter "b".
Mark For: BARICITINIB™ trademark registration is intended to cover the category of
Website | www.lilly.com |
Research | OneLook Acronym Finder |
Serial Number | 90240075 |
Mark Literal Elements | BARICITINIB |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | Trademark |
Standard Character Claim | No |
Current Location | GENERIC WEB UPDATE 2021-07-06 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Bruce W. Longbottom |
2020-10-07 | Application Filed |
2020-10-10 | Location: NEW APPLICATION PROCESSING |
2020-10-10 | Status: Live/Pending |
2020-10-10 | Transaction Date |
2021-07-06 | Location: GENERIC WEB UPDATE |
2021-07-06 | Status: Application withdrawn by USPTO before publication for further review. |
Party: | Eli Lilly and Company |
Address | Lilly Corporate Center Indianapolis, INDIANA UNITED STATES 46285 |
Legal Entity Type | Corporation |
Legal Entity State | INDIANA |
Application | MULTI | 2020-10-07 |
Drawing | IMAGE/JPEG | 2020-10-07 |
Design Search Code Corr Project | APPLICATION/XML | 2020-11-21 |
summary-SearchSummary202103251537550730400529 | 2021-03-25 | |
summary-SearchSummary202103251835347090400396 | APPLICATION/PDF | 2021-03-25 |
Examiner's Amendment | 2021-03-26 | |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2021-03-27 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2021-04-01 |
Administrative Response | MULTI | 2021-06-22 |
26.17.09 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
260328 | Miscellaneous designs with overall oval shape, including amoeba |
261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
DM0000 | The mark consists of stylized word "Baricitinib" with the first four letters "Bari" bolded and two curved lines, bands or streaks, one curving down and one curving up intersecting over the letter "b". |
Description | Date | Proceeding Number |
---|---|---|
WITHDRAWN FROM PUB - OG REVIEW QUERY | 2021-07-06 | 99910 |
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | 2021-06-23 | 72008 |
LETTER OF PROTEST EVIDENCE FORWARDED | 2021-06-22 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-03-31 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-03-26 | |
EXAMINERS AMENDMENT E-MAILED | 2021-03-26 | |
EXAMINERS AMENDMENT -WRITTEN | 2021-03-26 | 72008 |
EXAMINER'S AMENDMENT ENTERED | 2021-03-26 | 88888 |
ASSIGNED TO EXAMINER | 2021-03-24 | 72008 |
ASSIGNED TO EXAMINER | 2021-03-16 | 77656 |
ASSIGNED TO EXAMINER | 2021-03-06 | 76581 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2020-11-21 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-11-20 | |
NEW APPLICATION ENTERED IN TRAM | 2020-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.